| 17/01 | Top Premarket Gainers |  |
| 2022 | Sector Update: Health Care Stocks Post Moderate Gains Amid Broader Market .. | |
| 2022 | Sector Update: Health Care Stocks Advancing Wednesday Afternoon | |
| 2022 | Upbeat Nike Earnings Drive US Equity Futures Into Green Ahead of Consumer Confidence, H.. | |
| 2022 | Top Premarket Decliners | |
| 2022 | Celyad : arrêt du dernier programme clinique, le titre chute |  |
| 2022 | Celyad Oncology Tanks 48% on Decision to Stop Developing Blood Cancer Drug CYAD-211 | |
| 2022 | Celyad Oncology provides an update on its strategic business model, continuing to focus.. | |
| 2022 | Celyad Oncology : Request for proposal of external statutory Auditor mandate | |
| 2022 | Celyad Oncology Announces Third Quarter 2022 Financial Results and Recent Business High.. | |
| 2022 | Celyad Oncology Provides Strategic Update | |
| 2022 | Celyad : met à jour sa stratégie d'entreprise | |
| 2022 | Celyad Oncology Provides Update on Clinical Trial Programs | |
| 2022 | Celyad Oncology to Divest Cell Therapy Facility in Belgium for $6 Million | |
| 2022 | Celyad Oncology : vend son usine belge à Cellistic | |
| 2022 | Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transa.. | |
| 2022 | Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transa.. | |
| 2022 | Cellistic emtered into asset purchase agreement to acquire Manufacturing Business Unit .. | |
| 2022 | Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlight.. | |
| 2022 | Celyad : 14,4 millions d'euros de trésorerie à la fin juin | |
| 2022 | Celyad Oncology : Reports First Half 2022 Financial Results and Recent Business Highlights.. | |
| 2022 | Celyad Oncology SA Reports Earnings Results for the Half Year Ended June 30, 2022 | |
| 2022 | Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlight.. | |
| 2022 | Celyad Oncology présente ses Résultats Financiers pour le premier semestre de l'année 2.. | |
| 2022 | Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlight.. | |
| 2022 | Les valeurs à suivre demain à la Bourse de Paris Vendredi 5 août 2022 | |
| 2022 | Celyad Oncology : Announces FDA Lifts Clinical Hold of CYAD-101-002 Phase 1b Trial - Form .. | |
| 2022 | Wall Street Futures Consolidate After Strong End to July | |
| 2022 | Top Premarket Gainers | |
| 2022 | Celyad Oncology Shares Rally After FDA Lifts Study Hold | |
| 2022 | Celyad : les essais de phase 1b vont reprendre | |
| 2022 | Celyad Oncology Says FDA Lifts Clinical Hold on Phase 1b Trial of Colorectal Cancer Com.. | |
| 2022 | US FDA Lifts Clinical Hold on Celyad Oncology's Trial For CYAD-101 | |
| 2022 | Celyad Oncology Announces FDA Lifts Clinical Hold of CYAD-101-002 Phase 1b Trial | |
| 2022 | Celyad Oncology Sa Announces Fda Lifts Clinical Hold of Cyad-101-002 Phase 1B Trial | |
| 2022 | Celyad Oncology to Announce First Half 2022 Financial Results and Host Conference Call | |
| 2022 | Celyad : Filippo Petti démissionne du poste de CEO | |
| 2022 | Celyad Oncology : Announces Leadership Updates - Form 6-K | |
| 2022 | Celyad Oncology SA Announces Chief Financial Officer Changes | |
| 2022 | Celyad Oncology SA Announces Chief Executive Officer Changes | |
| 2022 | Celyad Oncology Names Michel Lussier Interim Chief Executive, Hilde Windels Chairwoman | |
| 2022 | Celyad Oncology Names New Chair, Interim CEO | |
| 2022 | Celyad Oncology Announces Leadership Updates | |
| 2022 | Celyad Oncology SA Announces Board Changes | |
| 2022 | Celyad Oncology : Summary Note – Listing Prospectus | |
| 2022 | Celyad Oncology : Security Note | |
| 2022 | Celyad Oncology : Registration Document | |
| 2022 | Celyad Oncology to Present at the H.C. Wainwright Global Investment Conference | |
| 2022 | Celyad Oncology SA Reports Earnings Results for the First Quarter Ended March 31, 2022 | |
| 2022 | Celyad Oncology : Ago - pv - fr | |
| 2022 | Celyad Oncology : Reports Full Year 2021 Financial Results and Recent Business Highlights .. | |
| 2022 | Celyad Oncology : Letter to Shareholders – March 2022 | |
| 2022 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2021 | |
| 2022 | Celyad Oncology Reports Full Year 2021 Financial Results and Recent Business Highlights | |
| 2022 | Celyad Oncology : to Announce Full Year 2021 Financial Results and Host Conference Call | |
| 2022 | Celyad : la suspension de l'essai de phase 1b confirmée | |
| 2022 | Celyad Says FDA Places Early-Stage Colorectal Cancer Trial on Clinical Hold | |
| 2022 | Celyad Oncology Slips 6% on US FDA's Clinical Hold on Colorectal Cancer Treatment Trial.. | |
| 2022 | Celyad Oncology Announces Clinical Hold of CYAD-101-002 Phase 1b Trial | |
| 2022 | Celyad Oncology Announces Clinical Hold of CYAD-101-002 Phase 1b Trial | |
| 2022 | Global markets live: Bayer, HP, Shell, Toshiba, Citigroup... | |
| 2022 | Bolsa de Madrid: Indagación sobre Rusia |  |
| 2022 | Haro sur la Russie | |
| 2022 | EN DIRECT DES MARCHES : Stellantis, Atos, TotalEnergies, EssilorLu.. | |
| 2022 | Celyad Oncology : Announces Voluntary Pause of CYAD-101-002 Phase 1b Trial - Form 6-K | |
| 2022 | Celyad : le titre chute après l'arrêt d'un essai de phase 1b | |
| 2022 | Celyad Pauses Early-Stage Colorectal Cancer Trial Amid Safety Issues | |
| 2022 | Celyad Oncology SA Announces Voluntary Pause of CYAD-101-002 Phase 1B Trial | |
| 2022 | Celyad Oncology Announces Voluntary Pause of CYAD-101-002 Phase 1b Trial | |
| 2022 | Celyad Oncology : Securities Note | |
| 2022 | Celyad Oncology : Summary Note – Listing Prospectus | |
| 2022 | Celyad Oncology Announces February 2022 Conference Schedule | |
| 2022 | Celyad Oncology : Provides Outlook for 2022 - Form 6-K | |
| 2022 | Celyad Oncology SA Announces Program Update and Anticipated Milestones for 2022 | |
| 2021 | Avis d'analystes du jour : Zur Rose, McPhy, Aker BP, Brenntag, .. | |
| 2021 | Celyad Oncology Announces January 2022 Conference Schedule | |
| 2021 | Transparency notification received from Tolefi SA and related persons (Article 14 §1 of.. | |
| 2021 | Celyad Oncology Sa : Notification de Transparence de Tolefi SA (Article 14§1 de la loi du .. | |
| 2021 | Celyad Oncology - Transparency notification received from Fortress Investment Group LLC | |
| 2021 | Celyad Oncology Doses First Patient in Trial of Colorectal Cancer Treatment | |
| 2021 | Celyad Oncology Announces First Patient Dosed in KEYNOTE-B79 Phase 1b Trial | |
| 2021 | Celyad Oncology SA Announces First Patient Dosed in KEYNOTE-B79 Phase 1b Trial | |
| 2021 | Celyad Oncology : Presents Updates on shRNA-Based CAR T Programs at the 63rd ASH Annual Me.. | |
| 2021 | Celyad Oncology : Transparency Notification Fortress Investment Group LLC | |
| 2021 | Celyad : mises à jour sur deux programmes cliniques | |
| 2021 | Celyad Oncology SA Presents Updates on shRNA-Based CAR T Programs at the 63rd ASH Annua.. | |
| 2021 | Global markets live: Apple, Volkswagen, Uber, Rolls-Royce, Gamestop... | |
| 2021 | EN DIRECTO DESDE LOS MERCADOS: GameStop, Adobe, Ercros, Ib.. | |
| 2021 | Gran incertidumbre sobre las previsiones para 2022 | |
| 2021 | EN DIRECT DES MARCHES : Vivendi, Lagardère, TotaEnergies, Veolia, .. | |
| 2021 | Grand flou sur les prévisions 2022 | |
| 2021 | Celyad Oncology Concludes $33 Million Private Placement | |
| 2021 | Celyad Oncology Closes $32.5 Million Share Sale to Fortress Investment Affiliate | |
| 2021 | Celyad Oncology : Announces Closing of $32.5 Million Private Placement with Fortress Inves.. | |
| 2021 | Celyad Oncology Announces Closing of $32.5 Million Private Placement with Fortress Inve.. | |
| 2021 | Celyad Oncology SA announced that it has received €28.73 million in funding from F.. | |
| 2021 | Celyad Oncology : Report Accounting and financial info | |
| 2021 | Celyad Oncology Announces $32.5 Million Private Placement with Fortress | |
| 2021 | Health Care Stocks Drifting Lower Ahead of Weekend | |
| 2021 | Health Care Stocks Inching Lower But Outperform Most Industry Sectors | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
